This inventor holds 2 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignee: Elucida Oncology, Inc.. Active years: 2023-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2024
Title: Fei Wu: Innovator in Nanoparticle Drug Conjugates
Introduction
Fei Wu is a prominent inventor based in Plainsboro, NJ (US). He has made significant contributions to the field of oncology through his innovative work on nanoparticle drug conjugates. With a total of 2 patents, his research focuses on advanced methods for cancer treatment.
Latest Patents
Fei Wu's latest patents include groundbreaking technologies related to folate receptor targeted nanoparticle drug conjugates. These disclosures detail nanoparticle drug conjugates (NDC) that consist of ultrasmall nanoparticles, folate receptor (FR) targeting ligands, and linker-drug conjugates. The methods outlined in these patents aim to enhance the efficacy of cancer treatments.
Career Highlights
Fei Wu is currently associated with Elucida Oncology, Inc., where he continues to push the boundaries of cancer research. His work is instrumental in developing targeted therapies that can potentially improve patient outcomes.
Collaborations
Fei Wu collaborates with talented individuals such as Kai Ma and Aranapakam Mudumbai Venkatesan. These partnerships foster a dynamic research environment that encourages innovation and discovery.
Conclusion
Fei Wu's contributions to nanoparticle drug conjugates represent a significant advancement in cancer treatment. His innovative approach and dedication to research continue to inspire progress in the field of oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile